Clinical trial
Bioavailability Of Flucloxacillin Capsules (250 mg and 500 mg)
NCT00358371 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00358371 |
|---|---|
| Title | Bioavailability Of Flucloxacillin Capsules (250 mg and 500 mg) |
| Official title | A Mono-center, Open, Randomized, Three-way, Twelve-sequence, Cross-over Study to Determine the Extent of Absorption (Absolute Bioavailability), Rate of Absorption and to Further Characterize Distribution and Elimination Characteristics of a Commercial 250 mg and a 500 mg Capsule of Flucloxacillin… |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Infections, Bacterial |
| Intervention type | Drug |
| Interventions | flucloxacillin 250 mg, flucloxacillin 500 mg |
| Enrollment | 24 |
| Start date | Jan 6, 2005 |
| Primary completion | Feb 8, 2005 |
| Completion | Feb 8, 2005 |
| First posted | Jul 31, 2006 |
| Last update posted | Sep 29, 2017 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: